Esomeprazole for cysteamine-induced gastrointestinal symptoms in children with cystinosis
Rachael Williams
This article has no abstract so we have provided the first paragraph of the full text.
The sulfhydryl agent cysteamine (also known as mercaptamine) is the only available treatment for CYSTINOSIS, but is often associated with compliance-compromising overproduction of gastric acid. Results of a small prospective investigation indicate that esomeprazole—a proton-pump inhibitor—slows gastric acid secretion and improves gastrointestinal symptoms in pediatric patients.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
